Infections and biological therapy in rheumatoid arthritis.
about
Whipple's disease diagnosed during anti-tumor necrosis factor alpha treatment: two case reports and review of the literatureChronic necrotizing pulmonary aspergillosis in a patient treated with a tumor necrosis factor-alpha inhibitor.Etanercept in the treatment of rheumatoid arthritisPerspectives on the use of gene therapy for chronic joint diseases.All-cause and cause-specific mortality in rheumatoid arthritis are not greater than expected when treated with tumour necrosis factor antagonists.Rheumatoid arthritis: acute presentations and urgent complications.Novel splice variants derived from the receptor tyrosine kinase superfamily are potential therapeutics for rheumatoid arthritis.Adenoviral pneumonia during etanercept treatment in a patient with rheumatoid arthritis.Septic arthritis in patients with rheumatoid arthritisLung Infections in Systemic Rheumatic Disease: Focus on Opportunistic Infections.New indications for biological therapies.Are biological targets the final goal for rheumatoid arthritis therapy?Human epidermal growth factor receptor bispecific ligand trap RB200: abrogation of collagen-induced arthritis in combination with tumour necrosis factor blockade.Comparison of the risk of infections in different anti-TNF agents: a meta-analysis.Exacerbation of Whipple's disease associated with infliximab treatment.Pneumocystis carinii pneumonia in a rheumatoid arthritis patient treated with adalimumab.Influence of methotrexate, TNF blockers and prednisolone on antibody responses to pneumococcal polysaccharide vaccine in patients with rheumatoid arthritis.Oral tuberculosis associated with a treatment with anti-rheumatic drugs.Genetic risk factors for infection in patients with early rheumatoid arthritisEfalizumabPatients with Moderate to Severe Plaque Psoriasis: One Year after the European Medicines Agency Recommendation of Efalizumab Suspension
P2860
Q26799217-E30A39CA-9993-43F5-86AC-2E01E4A48ED6Q34622449-8A403511-33C7-4443-9F00-804FBBED6AFCQ34764213-A2E44756-1C52-45F0-87E4-374A2B35C02EQ35151031-810F9BEC-099E-47C7-8593-E9FE926DA998Q35954490-E38AB1C8-E1BB-49DB-8B34-3B4F5C0608E5Q36490328-B5C23B18-7417-4A9A-A862-A69CC0DD8495Q36955347-B7BFD9EC-2E63-4B82-9429-7F32EA7F4B33Q37205173-9912F037-7379-4789-82B1-0333DB951368Q37228825-DC286BBD-65E8-4065-8DEF-4631C3B6871DQ37690737-44D3212E-F2C4-4AC2-B5FD-F7BE7DA5249CQ37947157-4F629C74-BBD2-447B-9842-D5D1B1F43A78Q38041208-14796BCA-2A6D-4C4F-BDAC-7906B9C854E5Q39699735-25CBFA0F-E3DD-4548-BE02-D79BD1F5855EQ40345791-F0CA9E04-2EC4-4774-836B-54179279F6D0Q40501467-B2CBF7D3-3F95-41F6-9F12-A226235737EDQ44487841-C68A5591-CBA5-4E26-9CE4-F3E040A58CACQ46803679-8BCFBA8E-EAF6-424D-89C4-454A5ED3AC67Q51822444-C8B377B1-D40F-41CD-905A-74A6FA812140Q57332116-970D8CF8-B027-4696-BE37-BC24319DFA54Q58434864-A07DEF41-7AA4-462D-9123-A6B6F0FA8058Q58434874-552152F0-561E-4F35-8203-67BECB20FD83
P2860
Infections and biological therapy in rheumatoid arthritis.
description
2003 nî lūn-bûn
@nan
2003 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Infections and biological therapy in rheumatoid arthritis.
@ast
Infections and biological therapy in rheumatoid arthritis.
@en
type
label
Infections and biological therapy in rheumatoid arthritis.
@ast
Infections and biological therapy in rheumatoid arthritis.
@en
prefLabel
Infections and biological therapy in rheumatoid arthritis.
@ast
Infections and biological therapy in rheumatoid arthritis.
@en
P2093
P1476
Infections and biological therapy in rheumatoid arthritis.
@en
P2093
Barry Bresnihan
Gaye Cunnane
Michele Doran
P304
P356
10.1016/S1521-6942(02)00107-9
P577
2003-04-01T00:00:00Z